Effects of Prehabilitation in Gastric Cancer Patients With Metabolic Syndrome on Perioperative Outcome

Qingdao University82 enrolled

Overview

A prospective randomised controlled trial to investigate the effects of a pre-operative prehabilitation protocol on clinical outcomes of gastric cancer patients with metabolic syndrome who undergo laparoscopic radical gastrectomies and to determine the underlying mechanisms.

To investigate the effects of a pre-operative prehabilitation protocol on clinical outcomes of gastric cancer patients with metabolic syndrome who undergo laparoscopic radical gastrectomies and to determine the underlying mechanisms.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Stomach Neoplasms Metabolic Syndrome X

Interventions

pre-operative prehabilitationBEHAVIORAL

To climb six flights of stairs (approximately 20 meters in height) at least 6 times as a daily routine and adaptive simulated training of restrictive ventilation dysfunction (increased thoracic and decreased abdominal breathing compliance) following abdominal surgery by using a full elastic breathable abdominal bandage.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * histologically-proven pre-operative stage I-III gastric cancer * Combined with metabolic syndrome * Age limits from 18 to 80 years old * Classified into American Society of Anesthesiology (ASA) II or III surgical risk * no history of abdominal surgery on organs located at the abdominal supramesocolic level Exclusion Criteria: * Combined with severe cardiac or pulmonary disease or other organ dysfunction * ASA IV * The history of abdominal surgery * Conversion to open surgery * The presence of gastrointestinal obstruction, perforation or necrosis; * Declined to participate in this study

Locations (1)

the Affiliated Hospital of Qingdao University

Qingdao, Shandong, China

Outcomes

Primary Outcomes

The proportion of postoperative complications

Time frame: up to six months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.